CAR T-cells for CLL: ibrutinib pre-treatment, T-cell quality and future predictions

We know that CAR T-cell therapy is effective in the treatment of chronic lymphocytic leukemia (CLL); however, a current limitation is the collection of high quality originator T-cells from patients. S... Author: VJHemOnc Added: 02/19/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts